UCIVIDY
Dead / Abandoned — Abandoned — no statement of use filed (as of 05 Jan 2026)
What this means for you
This application is over — abandoned 05 Jan 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97860535
- Mark type
- Stylized text
- Filed
- 28 Mar 2023
- Published for opposition
- 08 Apr 2025
- Abandoned
- 05 Jan 2026
- Attorney of record
- Kevin S. Costanza
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis; pharmaceutical preparations for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis; pharmaceutical agents for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis
Owner
- Athira Pharma, Inc., Bothell, WA, US
- Athira Pharma, Inc., Bothell, WA, US
Prosecution history
- 05 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 05 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Mar 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 04 Dec 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 04 Dec 2024 — FINAL REFUSAL E-MAILED
- 04 Dec 2024 — FINAL REFUSAL WRITTEN
- 25 Oct 2024 — ASSIGNED TO EXAMINER
- 16 Jul 2024 — ASSIGNED TO EXAMINER